Cancer Research Audrey Hepburn Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, K.
Right arrow Articles by Kline, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, K.
Right arrow Articles by Kline, K.
[Cancer Research 64, 4263-4269, June 15, 2004]
© 2004 American Association for Cancer Research

Regular Articles

Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA

Kristen Anderson1, Marla Simmons-Menchaca1, Karla A. Lawson2, Jeffrey Atkinson3, Bob G. Sanders1 and Kimberly Kline2

1 School of Biological Sciences/C0900 and 2 Division of Nutrition/A2703, University of Texas at Austin, Austin, Texas, and 3 Department of Chemistry, Brock University, St. Catharines, Ontario, Canada

A vitamin E derivative, vitamin E succinate (VES; RRR-{alpha}-tocopheryl succinate), and a vitamin E analogue, 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid ({alpha}-TEA), induce human breast, prostate, colon, lung, cervical, and endometrial tumor cells in culture to undergo apoptosis but not normal human mammary epithelial cells, immortalized, nontumorigenic breast cells, or normal human prostate epithelial cells. Human ovarian and cervical cancer cell lines are exceptions, with {alpha}-TEA exhibiting greater proapoptotic effects. Although both VES and {alpha}-TEA can induce A2780 and subline A2780/cp70 ovarian cancer cells to undergo DNA synthesis arrest within 24 h of treatment, only {alpha}-TEA is an effective inducer of apoptosis. VES or {alpha}-TEA treatment of cp70 cells with 5, 10, or 20 µg/ml for 3 days induced 5, 6, and 19% versus 9, 36, and 71% apoptosis, respectively. Colony formation data provide additional evidence that cp70 cells are more sensitive to growth inhibition by {alpha}-TEA than VES. Differences in stability of the ester-linked succinate moiety of VES versus the ether-linked acetic acid moiety of {alpha}-TEA were demonstrated by high-performance liquid chromatography analyses that showed {alpha}-TEA to remain intact, whereas VES was hydrolyzed to the free phenol, RRR-{alpha}-tocopherol. Pretreatment of cp70 cells with bis-(p-nitrophenyl) phosphate, an esterase inhibitor, before VES treatment, resulted in increased levels of intact VES and apoptosis. Taken together, these data show {alpha}-TEA to be a potent and stable proapoptotic agent for human ovarian tumor cells and suggest that endogenous ovarian esterases can hydrolyze the succinate moiety of VES, yielding RRR-{alpha}-tocopherol, an ineffective apoptotic-inducing agent.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
T. Hahn, K. Fried, L. H. Hurley, and E. T. Akporiaye
Orally active {alpha}-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer
Mol. Cancer Ther., June 1, 2009; 8(6): 1570 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Ni, T. Mai, S.-T. Pang, I. Haque, K. Huang, M. A. DiMaggio, S. Xie, N. S. James, D. Kasi, S. R. Chemler, et al.
In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-{alpha}-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer
Clin. Cancer Res., February 1, 2009; 15(3): 898 - 906.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Hahn, L. Szabo, M. Gold, L. Ramanathapuram, L. H. Hurley, and E. T. Akporiaye
Dietary Administration of the Proapoptotic Vitamin E Analogue {alpha}-Tocopheryloxyacetic Acid Inhibits Metastatic Murine Breast Cancer
Cancer Res., October 1, 2006; 66(19): 9374 - 9378.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Donapaty, S. Louis, E. Horvath, J. Kun, S. M. Sebti, and M. P. Malafa
RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling.
Mol. Cancer Ther., February 1, 2006; 5(2): 309 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
K. Anderson, K. A. Lawson, M. Simmons-Menchaca, L. Sun, B. G. Sanders, and K. Kline
{alpha}-TEA Plus Cisplatin Reduces Human Cisplatin-Resistant Ovarian Cancer Cell Tumor Burden and Metastasis
Experimental Biology and Medicine, December 1, 2004; 229(11): 1169 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
K. Kline, W. Yu, and B. G. Sanders
Vitamin E and Breast Cancer
J. Nutr., December 1, 2004; 134(12): 3458S - 3462S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.